Pfizer Claims Victory in mRNA Flu Vaccine Trial — Critics Push Back Citing Flaws, Gaps and Safety Signals

by Michael Nevradakis, Ph.D.

Pfizer said its mRNA flu vaccine outperformed conventional flu vaccines in a Phase 3 clinical trial. The New England Journal of Medicine (NEJM) last week published the results of the study, which Pfizer funded.

The vaccine delivered “statistically superior efficacy” compared to the conventional shot, and the trial demonstrated an “acceptable safety profile,” Pfizer said.

However, some experts said the results showed a higher rate of adverse events among the group that received the mRNA vaccine compared with the placebo group.

Other critics pointed out flaws in Pfizer’s trial, and some suggested that the mRNA vaccine technology itself is unsafe…

READ FULL ARTICLE HERE… (childrenshealthdefense.org)

 

---

Home | Caravan to Midnight (zutalk.com)

We Need Your Help To Keep Caravan To Midnight Going,

Please Consider Donating To Help Keep Independent Media Independent